CBD and cannabis trademark disputes can reach the Trademark Trial and Appeal Board in three principal ways: a company may oppose a competitor’s pending trademark application, seek cancellation of an existing registration, or appeal a USPTO refusal to register its own mark. The TTAB decides federal trademark registration rights. It generally does not decide trademark infringement, stop marketplace use, or award damages.
Cannabis cases can be unusually complicated because ordinary trademark issues such as likelihood of confusion and priority may overlap with questions about lawful use, federal cannabis regulation, CBD product categories, state licensing, first-use evidence, and the relationship between marijuana, hemp, and ancillary goods or services.
A CBD company may have convincing evidence that it used a brand first but still face questions about whether the underlying commercial activity can support the federal trademark rights being asserted.
Likewise, winning a TTAB opposition may prevent a competitor from obtaining a federal registration without actually requiring the competitor to stop using the name.
Understanding the Board’s role is therefore essential before deciding whether to oppose, cancel, appeal, negotiate, or file a lawsuit.
What Is the Trademark Trial and Appeal Board?
The Trademark Trial and Appeal Board, commonly called the TTAB, is an administrative tribunal within the United States Patent and Trademark Office.
The Board decides several types of trademark matters.
In an ex parte appeal, a trademark applicant asks the TTAB to review a final refusal issued by a USPTO examining attorney.
In an opposition, one party challenges a pending trademark application before it registers.
In a cancellation proceeding, a party challenges a trademark that has already registered.
The procedural rules governing these cases are contained principally in the Trademark Rules and the Trademark Trial and Appeal Board Manual of Procedure, commonly called the TBMP.
As of September 1, 2026, the current manual is the June 2026 TBMP.
Does the TTAB Handle CBD and Cannabis Trademark Cases?
Yes.
CBD, hemp, and cannabis trademarks are subject to the same basic TTAB framework as trademarks in other industries.
A CBD brand owner can oppose an application it believes is confusingly similar to its earlier trademark.
A hemp company can seek cancellation of a registration that interferes with its own rights.
A cannabis applicant can appeal a final USPTO refusal involving likelihood of confusion, descriptiveness, failure to function, lawful use, or another registrability issue.
What makes these cases different is the regulatory environment surrounding the underlying products.
Questions about hemp status, CBD ingredients, therapeutic claims, marijuana licensing, DEA regulation, FDA requirements, and historical product legality can become intertwined with ordinary trademark issues.
What Can the TTAB Decide?
The TTAB decides whether a federal trademark application is entitled to registration or whether an existing registration should remain on the register.
That jurisdiction is narrower than many brand owners initially expect.
In an opposition, the Board can prevent the challenged application from registering.
In a cancellation proceeding, the Board can cancel all or part of an existing registration when the petitioner proves an available statutory ground.
In an ex parte appeal, the Board can affirm or reverse a USPTO examining attorney’s refusal.
These remedies can have significant commercial consequences, but they do not give the TTAB the same powers as a federal district court.
Can the TTAB Stop a Cannabis Company From Using Its Name?
Generally, no.
The TTAB determines registration rights, not the general right to continue using a trademark in commerce.
A successful opposer can prevent a competitor’s application from registering, but the Board does not ordinarily issue an injunction requiring the applicant to stop using the brand.
Likewise, cancellation of a registration removes federal registration rights but does not automatically remove products from the marketplace.
If a CBD or cannabis company wants an order requiring another party to stop commercial use, infringement litigation may be necessary.
This distinction should be considered before choosing a forum.
Can the TTAB Award Damages in a CBD Trademark Dispute?
No.
The TTAB does not award infringement damages, lost profits, or other monetary compensation arising from marketplace infringement.
It also does not ordinarily adjudicate trademark infringement or unfair competition claims.
Those remedies are generally pursued through federal or state court litigation.
A business whose principal objective is to block a federal registration may find the TTAB appropriate.
A business that needs an injunction, monetary relief, or resolution of broader marketplace misconduct may need a court proceeding instead or in addition.
What Is a TTAB Opposition?
A trademark opposition is a proceeding challenging a pending application before registration.
After the USPTO examining attorney approves an application, the mark is ordinarily published in the Trademark Official Gazette.
Publication creates a limited period during which another party can oppose registration.
An opposer may assert that registration would damage its own trademark interests and plead an available statutory ground for refusing the application.
For CBD and cannabis brands, oppositions commonly involve allegations of likelihood of confusion, but other grounds may also be available depending on the facts.
How Long Does a CBD Company Have to Oppose a Trademark?
The initial opposition period is 30 days from the application’s publication date.
During that period, a potential opposer may file a Notice of Opposition or an available request for an extension of time to oppose.
This deadline makes trademark monitoring important.
If a CBD company discovers a problematic application after it has already registered, opposition is no longer the appropriate procedure. The business may instead need to evaluate a petition for cancellation or another enforcement strategy.
Monitoring should therefore focus not only on registered marks but also on newly published applications.
What Grounds Can Be Used in a TTAB Opposition?
A party must plead both an entitlement to a statutory cause of action and an available statutory basis for refusing registration.
Likelihood of confusion under Section 2(d) is one of the most common grounds.
Other potential claims can include descriptiveness, genericness, dilution where the statutory requirements are satisfied, lack of bona fide intent to use the mark, fraud, nonownership, and other grounds provided by federal trademark law.
The available claims depend on the facts.
Merely stating that the competitor copied the brand or that the opposer dislikes the application is not enough.
The pleading must allege facts that, if proven, establish a legally recognized basis for refusing registration.
How Much Does It Cost to File a TTAB Opposition in 2026?
As of September 1, 2026, the USPTO fee for an electronically filed Notice of Opposition is $600 per class opposed.
That is the government filing fee, not the total cost of litigating the proceeding.
A case that proceeds through pleadings, discovery, motions, testimony, trial evidence, briefing, and potentially oral argument can involve substantially greater legal expense.
The number of classes challenged can also affect the initial filing fee.
A brand owner should therefore evaluate the commercial significance of the application before initiating an opposition.
What Is a TTAB Cancellation Proceeding?
A cancellation proceeding challenges a trademark that has already registered.
The petitioner asks the Board to cancel all or part of the registration based on an available statutory ground.
A cancellation can involve the entire registration or, depending on the claim and circumstances, particular goods or services.
For example, a CBD company may believe that an earlier registration is blocking its own application even though the registrant never established valid rights for certain goods.
Another dispute may concern priority and likelihood of confusion.
The correct cancellation theory depends on the registration, its age, the register on which it appears, the goods or services, and the facts supporting the challenge.
Can a CBD Trademark Registration Be Challenged at Any Time?
Some cancellation grounds can be asserted at any time, while others are subject to statutory timing restrictions.
For a registration on the Principal Register, many grounds that could have prevented registration initially must be asserted within five years of registration.
After the five-year period, the available grounds become more limited under Section 14 of the Trademark Act.
Different timing rules apply to certain claims, including statutory nonuse and expungement-related grounds, and Supplemental Register registrations are subject to different rules in important respects.
A company should therefore not assume that every cancellation claim remains available indefinitely.
The registration date should be reviewed as soon as a potential conflict is discovered.
How Much Does a TTAB Cancellation Cost in 2026?
The current USPTO filing fee for an electronically filed petition for cancellation is $600 per class challenged.
As with an opposition, that is only the government filing fee.
The ultimate cost of a cancellation proceeding depends heavily on whether the case settles early or proceeds through contested discovery, motions, trial evidence, briefing, and appeal.
Before filing, a petitioner should identify the exact registration and classes it actually needs to challenge.
What Is an Ex Parte TTAB Appeal?
An ex parte appeal occurs when a trademark applicant challenges a final refusal issued by a USPTO examining attorney.
Unlike an opposition or cancellation, there is no private plaintiff on the other side.
The dispute is between the applicant and the USPTO over whether the application satisfies federal registration requirements.
For CBD and cannabis applicants, an ex parte appeal might involve a refusal based on lawful use, likelihood of confusion, descriptiveness, specimen issues, failure to function, or another registrability requirement.
The Board reviews the issues presented by the examining attorney’s final refusal based on the evidentiary record created during examination.
Can a CBD Applicant Appeal a Lawful-Use Refusal?
Yes.
An applicant that receives a final lawful-use refusal may appeal to the TTAB.
Cannabis-related applicants have done so in several significant cases.
One of the most important is the precedential 2020 decision In re Stanley Brothers Social Enterprises, LLC.
The applicant sought registration of CW for hemp oil extracts sold as an integral component of dietary and nutritional supplements.
The TTAB affirmed the refusal because the record established that the CBD-containing goods violated the Federal Food, Drug, and Cosmetic Act.
The decision demonstrates an important principle that remains relevant to CBD trademark applications: satisfying a hemp-related exception to the Controlled Substances Act does not necessarily resolve a separate FDCA problem.
What Did In re Stanley Brothers Decide?
The Board concluded that the applicant’s CBD-containing dietary and nutritional supplement goods could not support lawful trademark use under the FDCA.
The applicant argued in part that its hemp fell within federal industrial-hemp provisions.
That did not resolve the separate food-and-drug issue.
The Board found the identified goods to constitute a per se violation of the FDCA and affirmed the refusal to register.
The case remains an important authority because it shows why CBD trademark analysis must examine the actual product category rather than stopping at the question of THC concentration or hemp origin.
Can a CBD Applicant Introduce New Evidence for the First Time on TTAB Appeal?
Generally, no.
This is one of the most important procedural differences between building the examination record and writing the appeal brief.
Under the current TMEP and TBMP, the evidentiary record should ordinarily be complete before the appeal is filed.
Evidence first submitted with an appeal brief is generally untimely and may be excluded.
When additional evidence becomes necessary after the appeal is filed, the applicant may need to pursue an available procedure for requesting suspension and remand so the examining attorney can consider the material.
A CBD applicant facing a lawful-use refusal should therefore build the factual and regulatory record during examination rather than assuming missing evidence can simply be attached to the TTAB appeal brief later.
Why Is the Examination Record So Important in a Cannabis Appeal?
Lawful-use refusals can depend on highly specific facts.
The examining attorney may rely on product labels, website statements, ingredients, CBD content, intended use, FDA materials, state licensing, or other evidence.
If the applicant disputes those conclusions, it should generally submit responsive evidence while the application is still being examined.
For example, the company may need to establish the actual nature of the goods, explain an identification, address regulatory assumptions, or distinguish evidence cited by the examining attorney.
Waiting until the appeal brief to produce those materials can be too late.
For cannabis applicants, Office Action strategy and appeal strategy should therefore be planned together.
Is Likelihood of Confusion Common in CBD TTAB Cases?
Yes.
Cannabis and CBD brands are subject to the same basic Section 2(d) framework as other trademarks.
Two marks do not have to be identical.
The Board considers the marks’ similarities and differences in appearance, sound, meaning, and overall commercial impression, together with the relationship between the goods or services and other relevant factors.
For example, a CBD skincare mark may potentially conflict with a similar trademark covering cosmetics, body oils, wellness products, or closely related retail services.
A cannabis-industry software platform may present a very different relationship to physical cannabinoid products.
The analysis depends on the marks and the goods or services identified in the involved applications and registrations.
Do Trademark Classes Decide a CBD TTAB Likelihood-of-Confusion Case?
No.
International classes are administrative.
Goods and services in different classes can still be related for Section 2(d) purposes.
A registration for cosmetics and an application for online retail store services featuring cosmetics may occupy different classes but still present commercially related offerings.
Likewise, merely appearing in the same international class does not automatically make two products legally related.
The Board focuses on the identified goods and services and the relevant marketplace relationship.
Why Does the Identification of Goods Matter So Much at the TTAB?
In many TTAB cases, the Board evaluates the goods and services according to the wording appearing in the involved application or registration.
That can have significant consequences.
A party may argue that its actual customers are sophisticated or that its products are sold only through specialized channels.
If the identification contains no such restriction, the Board may not treat the party’s current business practices as limiting the legal scope of the application or registration.
Broad identifications can therefore create broader assumptions about customers and trade channels.
CBD businesses should pay close attention to identification wording both when filing applications and when evaluating a potential TTAB dispute.
How Is Trademark Priority Proven in a CBD TTAB Case?
Priority generally requires evidence establishing earlier valid trademark rights.
Depending on the case, relevant evidence can include dated product packaging, invoices, sales records, shipping documents, wholesale agreements, online orders, archived webpages, advertisements, distributor records, and testimony from witnesses with personal knowledge.
The evidence should establish more than the existence of a proposed brand.
Forming an LLC, registering a domain, creating a logo, or announcing an upcoming CBD product does not necessarily prove qualifying trademark use.
The evidence should connect the mark with genuine commercial activity involving the relevant goods or services.
Why Should CBD Companies Preserve First-Use Evidence?
Trademark disputes often begin years after a brand launches.
By then, the people who handled the launch may have left the company.
An outside marketing agency may no longer maintain the original website files. A private-label manufacturer may have replaced its records. Packaging may have been redesigned multiple times.
Reconstructing the first commercial use of a mark after litigation begins can therefore be difficult.
CBD and hemp companies should preserve ordinary business records as they launch products rather than attempting to recreate the history later.
Reliable records can become particularly important when both parties claim earlier rights.
Can Unlawful Cannabis Use Establish TTAB Priority?
Lawful use can significantly complicate a cannabis priority dispute.
Federal trademark registration requires lawful use in commerce.
A company asserting early CBD or marijuana sales may therefore need to establish more than the date on which a product first appeared.
Questions can arise concerning what the product contained, how it was marketed, whether the asserted use complied with applicable federal law, and whether the use can support the federal trademark rights being claimed.
This does not necessarily mean a regulatory issue automatically resolves every possible state-law or common-law trademark claim.
The legal consequence depends on the rights being asserted and the forum.
For TTAB purposes, however, the lawfulness of claimed use can become highly significant.
What Evidence Can Matter in a Cannabis Lawful-Use Dispute?
The evidence depends on the product.
A cannabis case may involve product formulations, cannabinoid content, certificates of analysis, labels, packaging, state licenses, DEA registrations, FDA approvals, website claims, therapeutic statements, manufacturing records, and historical sales documentation.
The legal framework may also differ depending on whether the goods involve marijuana, qualifying hemp, CBD cosmetics, CBD foods, dietary supplements, pharmaceuticals, clothing, software, or another ancillary product or service.
A company asserting priority should therefore understand exactly what commercial activity occurred during the period it relies upon.
Does Marijuana Rescheduling Affect TTAB Cannabis Cases in 2026?
Potentially, but the applicable law must be evaluated according to the specific goods, activity, and time period involved.
Federal marijuana regulation changed in April 2026 for specified FDA-approved marijuana products and marijuana subject to qualifying state medical-marijuana licenses.
A separate federal rulemaking proceeding concerning broader movement of marijuana from Schedule I to Schedule III has also continued during 2026.
As of September 1, 2026, DEA still describes that broader action as a proposed rescheduling proceeding.
For TTAB priority and lawful-use questions, businesses should therefore avoid applying today’s regulatory status retroactively to commercial activity that occurred years earlier.
The relevant question may be what federal law permitted when the asserted trademark use actually occurred.
What Happens During Discovery in a TTAB Opposition or Cancellation?
TTAB oppositions and cancellations can include a substantial discovery phase.
The June 2026 TBMP explains that the Federal Rules of Civil Procedure governing disclosure and discovery apply to Board proceedings in modified form.
Discovery can include interrogatories, requests for production of documents, requests for admission, and discovery depositions.
The Board’s institution order sets important deadlines, including the discovery conference, initial disclosures, discovery period, pretrial disclosures, testimony periods, and briefing schedule.
A company should treat those deadlines as litigation deadlines rather than ordinary USPTO application correspondence.
What Is the TTAB Discovery Conference?
Parties to an inter partes TTAB proceeding generally must conduct a discovery conference.
The conference must occur by the deadline established by the Board and no later than the opening of the discovery period.
During the conference, the parties address the nature and basis of their claims and defenses, settlement possibilities, disclosure and discovery arrangements, preservation of discoverable information, and introduction of evidence.
The parties may also discuss ways of narrowing the case.
A Board interlocutory attorney or administrative trademark judge can participate when properly requested within the applicable time requirements.
For CBD disputes, the discovery conference is an opportunity to identify early whether product-legality evidence, sensitive formulations, licensing records, or regulatory documentation will become central to the case.
What Can Be Discovered in a CBD or Cannabis TTAB Case?
Discovery is generally tied to the claims and defenses in the proceeding and remains subject to proportionality and other procedural limitations.
Depending on the issues, a CBD or cannabis case may involve sales figures, advertising expenditures, distribution channels, customer classes, product packaging, first-use documents, trademark adoption records, licenses, manufacturing relationships, certificates of analysis, or product-related regulatory evidence.
A likelihood-of-confusion case may require different evidence from a lawful-use or bona fide-intent dispute.
Not every category of business information is automatically discoverable simply because one party requests it.
The requesting party should connect the information sought to issues actually being litigated.
Are Customer Lists Discoverable in a TTAB Case?
The current TBMP distinguishes between classes of customers and the identities of individual customers.
Information concerning the classes of customers for the involved goods or services is generally discoverable.
Actual customer names are ordinarily treated much more restrictively and can involve confidentiality concerns.
Certain limited exceptions may apply, including circumstances involving the first customer or particular abandonment questions.
This distinction can be important in CBD cases where companies sell through distributors, wholesale accounts, dispensaries, specialty retailers, or direct-to-consumer channels.
Are CBD Formulas and Sales Records Public in a TTAB Case?
Not necessarily.
The Board’s standard protective order automatically applies in opposition, cancellation, and concurrent-use proceedings.
The protective order provides mechanisms for designating confidential information and, for highly sensitive material, certain commercially sensitive information.
CBD companies producing formulas, certificates of analysis, pricing information, revenue data, manufacturing agreements, or other sensitive records should understand the protective-order procedures before production begins.
Confidential material must also be handled correctly when later filed with the Board.
Simply calling something confidential does not automatically justify sealing every document.
Are TTAB Discovery Documents Automatically Evidence at Trial?
No.
This is one of the most important procedural concepts in TTAB litigation.
Producing a document during discovery does not automatically make that document part of the evidentiary record considered at final decision.
The parties must introduce evidence through a method permitted by the Trademark Rules and TTAB procedure.
Depending on the evidence, that may involve testimony, an appropriate notice of reliance, a stipulation, or another authorized method.
The June 2026 TBMP specifically requires notices of reliance to be filed during the offering party’s testimony period and to explain the general relevance of the submitted materials and associate them with issues in the proceeding.
Possessing a helpful document and successfully making that document trial evidence are two different things.
Can Documents Produced by the Other Side Be Filed With a Notice of Reliance?
Not automatically.
The Board has specific rules governing the use of documents obtained through disclosure or document production.
A party generally cannot make ordinary produced documents trial evidence merely by attaching them to a notice of reliance unless the documents independently qualify for that procedure or have been properly authenticated through an admission, stipulation, deposition, or another permitted mechanism.
The current TBMP specifically provides procedures for using requests for admission to authenticate produced documents.
Evidence strategy should therefore begin during discovery rather than waiting until the testimony period to determine whether critical documents can actually be introduced.
What Is a Notice of Reliance?
A notice of reliance is a procedural method for placing specified categories of evidence into the TTAB trial record without introducing each item through live witness testimony.
Depending on the circumstances, materials that may be submitted through notice of reliance include official records, printed publications, internet materials, certain discovery responses, certain discovery depositions of an adverse party, and other categories authorized by TTAB rules.
The notice must identify the evidence, explain its relevance, and associate it with one or more issues in the case.
Internet materials generally require information identifying the source and access date.
The fact that material appears somewhere in TTABVUE does not necessarily mean the Board will consider it at final decision.
Can a Strong CBD Trademark Case Be Lost Because Evidence Was Not Properly Introduced?
Yes.
A party can possess persuasive documents but fail to place them properly into the trial record.
For example, invoices supporting priority may have been exchanged during discovery without ever becoming evidence.
Important website materials might lack the necessary evidentiary foundation or source information.
Documents may be submitted outside the appropriate testimony period.
A witness may have relevant knowledge without providing admissible testimony.
TTAB litigation therefore requires attention to both the substance of the evidence and the procedure for introducing it.
Can a Federal Court Case and TTAB Proceeding Happen at the Same Time?
Yes.
A trademark dispute can involve both TTAB proceedings and federal litigation.
This frequently occurs when the parties disagree both about registration and marketplace use.
A district court can address infringement, unfair competition, injunctive relief, damages, and, in appropriate cases, the validity or cancellation of a federal registration.
Because the court proceeding may resolve issues that affect the TTAB case, the Board can suspend its proceeding while related litigation moves forward.
Forum strategy therefore matters.
Can the TTAB Suspend a Cannabis Trademark Case Because of a Lawsuit?
Yes.
The Board may suspend a proceeding when a pending civil action can have a bearing on the TTAB dispute.
A historical CBD example involved CBD Industries, LLC v. Majik Medecine, LLC, Cancellation No. 92071109, concerning the CBD MD registration.
The Board suspended the cancellation while related federal district-court litigation proceeded.
The case illustrates how a court proceeding involving overlapping registration and lawful-use issues can take priority over the TTAB matter.
The cancellation did not remain pending indefinitely. After the parties resolved their broader dispute, the petitioner withdrew the cancellation and the TTAB proceeding was terminated in September 2024.
For current disputes, the lesson is procedural rather than case-specific: when a federal lawsuit may determine issues central to a TTAB proceeding, suspension is possible.
When Is Federal Court Better Than the TTAB?
The answer depends largely on the remedy the business needs.
If the primary objective is to stop a pending federal registration, a TTAB opposition may directly address that goal.
If the objective is to cancel an existing registration, a TTAB cancellation may be appropriate.
If the company needs an injunction stopping marketplace sales, damages, or adjudication of infringement and unfair competition, federal court may offer remedies the TTAB cannot provide.
Some disputes justify parallel consideration of both forums.
The business should evaluate the desired result before filing rather than automatically choosing the TTAB merely because the dispute involves a trademark registration.
Do Most CBD TTAB Cases Go to Final Decision?
Not necessarily.
TTAB proceedings can resolve through settlement before final decision.
The parties may agree to coexist, modify their marks, restrict goods or services, change packaging, separate trade channels, abandon an application, surrender a registration, or adopt another negotiated solution.
Settlement can sometimes provide commercially useful terms that the Board itself could not order.
For example, the parties may agree on how trademarks will actually be used in the marketplace, something a final TTAB registration decision may not fully resolve.
Can a CBD Applicant Narrow Its Goods to Settle a TTAB Opposition?
Potentially.
Depending on the application and dispute, an applicant may agree to delete goods or services or accept a permissible narrowing amendment.
This can sometimes reduce the commercial overlap between the parties.
A software company and a CBD product company, for example, might be able to clarify their respective activities more effectively than two businesses selling nearly identical consumer products through the same channels.
Whether a restriction eliminates likely confusion depends on the marks, remaining goods or services, and marketplace relationship.
The restriction must also comply with USPTO rules governing amendments to identifications.
Can Two Cannabis Brands Sign a Coexistence Agreement During a TTAB Case?
Yes.
A settlement may include a coexistence or consent agreement.
The agreement can address trademark presentation, product categories, sales channels, geographic restrictions, packaging, future expansion, and procedures for handling confusion.
Where the TTAB case concerns a pending application, the parties may also agree on amendments or consent relevant to registration.
A useful settlement should address both the registration dispute and the actual commercial relationship if marketplace use is also at issue.
Ending only the TTAB proceeding may leave the business conflict unresolved.
What Happens if an Opposer Withdraws After the Applicant Has Answered?
The procedural consequences can change once an answer has been filed.
Under TTAB rules, a plaintiff generally cannot withdraw an opposition or cancellation without prejudice after the defendant has filed an answer unless the defendant provides written consent or the Board otherwise permits the disposition.
Without the necessary consent, withdrawal after answer can result in dismissal with prejudice.
This matters during settlement.
Parties should understand the procedural effect of withdrawal before filing settlement papers or notices with the Board.
What Is the Current TTAB Manual in 2026?
As of September 1, 2026, the current Trademark Trial and Appeal Board Manual of Procedure is the June 2026 edition.
The USPTO states that the June 2026 revision updates the June 2025 edition and incorporates relevant TTAB case law issued through February 27, 2026.
CBD and cannabis companies involved in TTAB litigation should therefore use current procedural materials rather than relying on an older TBMP version or outdated online article.
Procedure can be as important as substantive trademark law in a contested Board case.
How Should a CBD Company Prepare for a TTAB Opposition or Cancellation?
The company should begin by understanding its own trademark rights.
That includes reviewing federal applications and registrations, assignments, ownership records, first-use documentation, licensing agreements, product packaging, sales history, and the exact goods and services associated with each mark.
The business should then investigate the opposing party’s records.
Relevant information may include application and registration history, claimed priority, ownership, product categories, marketplace use, and any regulatory facts that may affect asserted cannabis-related rights.
The company should preserve potentially relevant electronic and physical evidence once litigation is reasonably anticipated.
It should also decide what result actually matters.
Preventing registration, stopping marketplace use, recovering money, protecting distribution relationships, and negotiating coexistence are different objectives and may justify different strategies.
What Should a Cannabis Company Preserve Before a TTAB Dispute Begins?
The safest approach is to preserve ordinary business records while the brand develops.
Priority evidence may include invoices, shipping records, order histories, dated packaging, photographs, archived webpages, advertising records, distributor agreements, and launch materials.
For regulated products, the company may also need certificates of analysis, product formulations, licenses, approvals, labeling history, and documents showing what the product actually contained or how it was marketed.
Ownership records and agreements with manufacturers, distributors, affiliates, and licensees should also be maintained.
The discovery conference specifically requires the parties to consider preservation of discoverable information, making evidence organization relevant from the earliest stages of the case.
What Are the Most Common Mistakes in CBD and Cannabis TTAB Cases?
One common mistake is assuming that the TTAB can stop a competitor’s marketplace use.
Another is waiting until after registration to notice a published application that could have been opposed.
Companies also create problems when they lack reliable first-use records, rely on overly descriptive marks, or fail to analyze whether the commercial activity supporting claimed federal rights was lawful.
Procedural mistakes can be equally damaging.
Important discovery materials may never be properly introduced as trial evidence. Confidential documents may be mishandled. An applicant may try to introduce evidence too late during an ex parte appeal. Settlement papers may be filed without understanding the effect of dismissal with prejudice.
TTAB disputes reward early preparation.
Frequently Asked Questions About CBD and Cannabis TTAB Disputes
Can a CBD company file a TTAB opposition?
Yes. A CBD company that believes it would be damaged by registration of a pending trademark may potentially file an opposition if it can plead an entitlement to a statutory cause of action and an available ground for refusing registration.
How long do I have to oppose a cannabis trademark?
The initial opposition period is 30 days after publication of the application. Available extensions may be requested under USPTO rules.
How much does a TTAB opposition cost?
As of September 1, 2026, the USPTO electronic filing fee is $600 per class opposed. Legal fees and other litigation costs are separate.
How much does a TTAB cancellation cost?
The current electronic USPTO filing fee is $600 per class challenged.
Can a CBD company cancel an existing trademark registration?
Potentially. The company must have an entitlement to a statutory cause of action and plead an available statutory cancellation ground. The registration’s age can affect which grounds remain available.
Can the TTAB stop a CBD competitor from using its trademark?
Generally, no. The Board determines registration rights. Injunctions against marketplace use generally require court relief.
Can the TTAB award money damages?
No. The TTAB does not award trademark-infringement damages.
Can a cannabis applicant appeal a USPTO refusal?
Yes. A final refusal to register can generally be appealed to the TTAB within the applicable deadline.
Can I submit new evidence with my TTAB appeal brief?
Generally not. The examination record should ordinarily be complete before the appeal is filed. New evidence first submitted on appeal can be excluded as untimely.
Can a CBD trademark be refused even if the CBD comes from hemp?
Yes. Hemp status may resolve one federal issue without resolving FDA or other federal-law concerns. In re Stanley Brothers Social Enterprises, LLC is an important example involving CBD-containing dietary and nutritional supplement goods.
Is discovery available in a TTAB case?
Yes. Inter partes proceedings can include interrogatories, requests for documents, requests for admission, and discovery depositions, subject to TTAB rules and applicable limits.
Are confidential CBD business records protected during TTAB discovery?
The Board’s standard protective order automatically applies in inter partes proceedings and provides procedures for handling qualifying confidential and commercially sensitive information.
Are discovery documents automatically part of the TTAB trial record?
No. Discovery and trial evidence are different. Evidence must be properly introduced through an authorized procedure.
Can a federal lawsuit pause a TTAB case?
Yes. The TTAB may suspend a proceeding when related civil litigation may have a bearing on the Board case.
Can CBD companies settle a TTAB dispute?
Yes. The parties may negotiate agreements concerning registration, goods and services, brand presentation, marketplace conduct, coexistence, abandonment, or other terms.
What happens if an opposer withdraws after an answer is filed?
After an answer, withdrawal without prejudice generally requires the defendant’s written consent or another proper basis. Otherwise, dismissal can be with prejudice.
What version of the TBMP should be used in 2026?
The current edition as of September 1, 2026 is the June 2026 Trademark Trial and Appeal Board Manual of Procedure.
Final Thoughts: TTAB Disputes Involving CBD and Cannabis Trademarks
CBD and cannabis TTAB disputes combine ordinary federal trademark law with an unusually complicated regulatory environment.
A case may involve likelihood of confusion, priority, descriptiveness, bona fide intent, ownership, nonuse, or another traditional trademark issue.
At the same time, the parties may need to address what the underlying cannabis product actually was, whether asserted trademark use was lawful, and which federal regulatory framework applied during the relevant period.
Brand owners should also understand the TTAB’s limited jurisdiction.
The Board can prevent an application from registering, cancel an existing registration, or review an examining attorney’s refusal.
It generally cannot order a competitor to stop marketplace use or award infringement damages.
Procedure matters as well.
Opposition deadlines are short. Discovery can expose sensitive business information. Documents produced during discovery do not automatically become trial evidence. Ex parte appeal records should ordinarily be completed before appeal. Settlement documents can have consequences depending on when and how the case is withdrawn.
For CBD and cannabis businesses, the best TTAB strategy begins before the proceeding is filed.
Monitoring published applications, preserving first-use evidence, maintaining accurate product and regulatory records, selecting distinctive marks, and identifying the desired remedy can make it easier to decide whether to oppose, cancel, appeal, settle, or seek relief in court.
Primary Authorities and Sources
The principal authorities relevant to this article include Sections 2(d), 13, 14, and 20 of the Trademark Act; 15 U.S.C. §§1052(d), 1063, 1064, and 1070; the Trademark Rules of Practice; the June 2026 Trademark Trial and Appeal Board Manual of Procedure; TMEP §907 concerning lawful use; TMEP §710.01(c) concerning completion of the examination record before appeal; TBMP Chapters 300, 400, 500, 600, 700, and 1200; the USPTO Standard Protective Order; and relevant Board decisions including In re Stanley Brothers Social Enterprises, LLC, 2020 USPQ2d 10658 (TTAB 2020).
Author: Abraham Cohn, Founder, Cohn Legal, PLLC. Abraham Cohn is a U.S. trademark attorney who represents businesses in trademark clearance, USPTO proceedings, TTAB oppositions and cancellations, federal registration matters, and trademark disputes.